SCIENTIFIC EVIDENCE

A pilot study on ex vivo expanded autologous adipose-derived stem cells of improving fat retention in localized scleroderma patients.

Stem cells translational medicine
Wang C, Long X, Si L, Chen B, Zhang Y, Sun T, Zhang X, Zhao RC, Wang X.

Publication Overview

Key findings, Countstar context, and access to the original paper.
2021
Immunology
Stem Cell Research
No items found.
Key Finding
The authors aimed to compare the feasibility and efficacy of improving fat retention in LoS patients among the ADSCs-assisted, the stromal vascular fraction (SVF)-assisted and conventional AFG. This pilot study suggests that ADSCs-assisted AFG is a safe, feasible, and attractive alternative to conventional and SVF-assisted AFG in the correction of facial atrophy of LoS patients.
Countstar Connection
Countstar (model not specified) quantified cell viability in the study's cell samples during quality assessment in the 2021 Stem cells translational medicine study.
View paper ↗
Stay Connected toCountstar Science
Get new publications, application notes, cell analysis insights, and Countstar updates delivered to your inbox.
Meet us online
Products
About Us
Contact
© 2026 Countstar. All rights reserved.